About Diabetic Cardiomyopathy

This collection is now closed to submissions.

With the global prevalence of diabetes mellitus, diabetic cardiomyopathy has been a significant public health problem with high mortality. Molecular, transcriptional, animal, and clinical studies have discovered new molecular mechanisms of diabetic cardiomyopathy, biomarkers, and therapeutic targets for diabetic cardiomyopathy. This collection aims to publish content relating to clinical phenotype and therapies, novel biomarkers, pathophysiological mechanisms, and new potential targets for future therapies. F1000Research welcomes submissions of a wide range of article types, including research articles, case reports, method articles, reviews, and opinion articles.  Each article will undergo fully transparent post-publication peer review following the F1000Research publication model.  We warmly encourage members of the community of diabetes mellitus and cardiovascular disease research to share their work here.

Keywords: Diabetic cardiomyopathy; diabetes mellitus; diastolic function; cardiac remodelling; epigenetics; mitochondria; cardiac energetics; fibrosis; inflammation

Submission deadline: 22nd July 2022

Any questions about this collection? Please get in contact directly with Amy Joint (amy.joint@f1000.com)